Evidence mapPaperPMID 40917796Full record

ReviewGlobal heart2025

The Silent Surge: Obesity Driving a Global Cardiovascular Crisis.

Panniyammakal Jeemon, Sivasankaran Sivasubramonian

Abstract readReview
In one paragraph

Review in Global heart, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Panniyammakal JeemonSree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.ORCID 0000-0003-4172-4307
Sivasankaran SivasubramonianManipal Academy of Higher Education, Manipal, Karnataka, India.ORCID 0000-0003-1456-6024

Funding

DBT-Wellcome Trust India Alliance IA/CPHS/20/1/505229NHLBI NIH HHS R01 HL125442
6 · The paper itself

Abstract

Recent global estimates indicate that more than one billion people live with obesity, a figure that has doubled since 1990. When overweight individuals are included, nearly 2.5 billion adults are affected, with high body mass index contributing to an estimated 1.9 million cardiovascular disease (CVD) deaths annually. Obesity and its close association with CVD remain pressing public health challenges that require sustained, coordinated action. Recent global policy discussions, including the UN General Assembly's Zero Draft Political Declaration, highlight the importance of improving food labelling, taxing sugary drinks, limiting the marketing of unhealthy foods, and encouraging active living through supportive urban planning. Countries are encouraged to align national obesity strategies with the WHO's 2022 Acceleration Plan to STOP Obesity, with clear goals and mechanisms for accountability and monitoring. Preventive measures are most effective when introduced early, such as encouraging breastfeeding and creating supportive school environments that offer balanced meals, limit access to unhealthy foods, and incorporate regular physical activity into daily schedules. Fiscal measures, including taxes, subsidies, and mandatory nutrition labels, can help guide consumer choices towards healthier options. Supportive built environments with safe access to parks, pedestrian routes, and cycling paths further encourage active lifestyles. Health systems are central in ensuring equitable access to prevention and treatment, delivered through stigma-free and evidence-based care. Community-based and family-oriented programs have shown promise, while pharmacological options may complement lifestyle approaches where appropriate. Long-term progress depends on sustained commitment, cross-sectoral collaboration, and integration of obesity prevention into broader public health frameworks.

Indexed as

Cardiovascular DiseasesObesityGlobal HealthHumansCardiovascular diseaseEquityInterventionsObesityRoadmap

Identifiers

PMID40917796
PMCPMC12412452

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.